Authors: List, AF Kopecky, KJ Willman, CL Head, DR Persons, DL Slovak, ML Dorr, R Karanes, C Hynes, HE Doroshow, JH Shurafa, M Appelbaum, FR

Citation: Af. List et al., Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study, BLOOD, 98(12), 2001, pp. 3212-3220

Authors: Pandya, KJ Raubertas, RF Flynn, PJ Hynes, HE Rosenbluth, RJ Kirshner, JJ Pierce, HI Dragalin, V Morrow, GR

Citation: Kj. Pandya et al., Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: A University of Rochester cancer center community clinical oncology program study, ANN INT MED, 132(10), 2000, pp. 788-793

Authors: Grunberg, SM Crowley, J Hande, KR Giroux, D Munshi, N Lan, DHM Schroder, LE Zangmeister, MH Balcerzak, SP Hynes, HE Gandara, DR

Citation: Sm. Grunberg et al., Treatment of poor-prognosis extensive disease small-cell lung cancer with an all-oral regimen of etoposide and cyclophosphamide - a Southwest Oncology Group clinical and pharmacokinetic study, CANC CHEMOT, 44(6), 1999, pp. 461-468

Authors: Karanes, C Kopecky, KJ Head, DR Grever, MR Hynes, HE Kraut, EH Vial, RH Lichtin, A Nand, S Samlowski, WE Appelbaum, FR

Citation: C. Karanes et al., A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia, LEUK RES, 23(9), 1999, pp. 787-794

Authors: Hickok, JT Roscoe, JA Morrow, GR Stern, RM Yang, B Flynn, PJ Hynes, HE Kirshner, JJ Rosenbluth, RJ

Citation: Jt. Hickok et al., Use of 5-HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings, CANCER, 86(1), 1999, pp. 64-71